ProCE Banner Activity

How I Managed 2 Challenging Patients With CLL During the COVID-19 Pandemic

Clinical Thought
Here I discuss 2 interesting cases from my practice: an older patient who needed to initiate therapy but was afraid to come to the clinic and a patient who developed COVID-19 while receiving venetoclax.

Released: November 13, 2020

Expiration: November 12, 2021

No longer available for credit.

Share

Faculty

John Pagel

John Pagel, MD, PhD

Associate Professor
Clinical Research Division
Fred Hutchinson Cancer Research Center
Seattle, Washington

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

AstraZeneca

Faculty Disclosure

Primary Author

John Pagel, MD, PhD

Associate Professor
Clinical Research Division
Fred Hutchinson Cancer Research Center
Seattle, Washington

John Pagel, MD, PhD, has disclosed that he has received consulting fees from AstraZeneca, BeiGene, Gilead Sciences, and Loxo.